Due to an extensive Associate Partners network, IMI can provide services in most therapeutic sectors and geographies.
Epidural (Devices)
Pain (Moderate-to-Severe/NSAID)
Opioids
Superagonistic Antibodies
Phytotherapies
Angiogenesis
HDAC Inhibitors
Human mAb
Small Molecules
Unique Drug Delivery
Autoimmune
New Targets
Supportive Care
Bispecific Antibodies
Immuno-Oncology
Coronary Artery By-Pass Surgery (CABS)
Acute Myocardial Infarctions (AMI)
Congestive Heart Failure (CHF)
Angina Pectoris
Restenosis
Hyperdislipidemia
Epilepsy
Alzheimer's
Parkinson's
Acne (severe)
Alopecia
Artificial Skin
Atopic Dermatitis
Psoriasis
Tissue Engineering
Wound Healing
Vitiligo
Antiseptics
Medtech implantable Type III devices
Diabetes unique inhaler for insulin etc.
Urinary Incontinence
Hormone Replacement (male/female)
FSD (female sexual dysfunction)
MSD
Crohn’s Disease
IBS
IBD
Reflux
Factors
Generics
Drug-Delivery (low/high tech)
Second and Third Indications
Diabetes I & II
Triglyceride Lowering
Prenatal
Cancer
SNP's
Ecogenetics
Circulating Tumor Cells
Asthma
COPD (chronic obstructive pulmonary disease)
Antisense
Nutritionals
Discovery Targets
Genomics
Stem Cells
Computational Discovery
mAbs
Dental Aids
OTCs
Autoimmune
Click here for Examples of Life-Science Projects.